Documents
Application Sponsors
BLA 761038 | ELI LILLY AND CO | |
Marketing Status
Application Products
001 | INJECTABLE; INJECTION | 500MG/50ML | 0 | LARTRUVO | OLARATUMAB |
FDA Submissions
TYPE 1; Type 1 - New Molecular Entity | ORIG | 1 | AP | 2016-10-19 | PRIORITY |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 9 | AP | 2018-08-09 | N/A |
Submissions Property Types
CDER Filings
ELI LILLY AND CO
cder:Array
(
[0] => Array
(
[ApplNo] => 761038
[companyName] => ELI LILLY AND CO
[docInserts] => ["",""]
[products] => [{"drugName":"LARTRUVO","activeIngredients":"OLARATUMAB","strength":"500MG\/50ML","dosageForm":"INJECTABLE; INJECTION","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"}]
[labels] => [{"actionDate":"10\/19\/2016","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/761038lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"10\/19\/2016","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"N\/A; Orphan","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/761038lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2016\\\/761038Orig1s000ltr.pdf\"},{\"name\":\"Review\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2016\\\/761038Orig1s000TOC.cfm\"}]","notes":">"}]
[supplements] => [{"actionDate":"08\/09\/2018","submission":"SUPPL-9","supplementCategories":"Supplement","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"07\/10\/2019","submission":"SUPPL-1","supplementCategories":"Supplement","inserts":"[{\"name\":\"Review (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2019\\\/761038Orig1s001.pdf\"}]","notes":"> Label is not available on this site."}]
[actionDate] => 2019-07-10
)
)